Balwinder Singh, MD, MS
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota
- 13Articles
- 207.6KReads1
- 2016–2026Active
- 42Collaborators
- 202Citations2
About
Balwinder Singh, MD, MS, is affiliated with the Department of Psychiatry and Psychology at Mayo Clinic in Rochester, Minnesota. Singh has published extensively on topics including major depressive disorder, treatment-resistant depression, addiction, anxiety, posttraumatic stress disorder, psychedelics, psychopharmacology, psychotherapy, and suicide. The work encompasses clinical studies and reviews on interventions such as ketamine, esketamine, lithium augmentation, selective serotonin reuptake inhibitors, thyroid hormone use, and adjunctive aripiprazole, as well as nonpharmacologic treatments like exercise, yoga, and tai chi. Singh's research has appeared in Psychiatrist.com from 2016 to 2026.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
